Nemaura Medical Price Prediction

NMRDDelisted Stock  USD 0.93  0.01  1.06%   
The relative strength index (RSI) of Nemaura Medical's pink sheet price is about 60. This indicates that the pink sheet is rather overbought by investors at the present time. The main point of the Relative Strength Index (RSI) is to track how fast people are buying or selling Nemaura, making its price go up or down.

Oversold Vs Overbought

60

 
Oversold
 
Overbought
The successful prediction of Nemaura Medical's future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Nemaura Medical and does not consider all of the tangible or intangible factors available from Nemaura Medical's fundamental data. We analyze noise-free headlines and recent hype associated with Nemaura Medical, which may create opportunities for some arbitrage if properly timed.
Using Nemaura Medical hype-based prediction, you can estimate the value of Nemaura Medical from the perspective of Nemaura Medical response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Nemaura Medical to buy its pink sheet at a price that has no basis in reality. In that case, they are not buying Nemaura because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell pink sheets at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Nemaura Medical after-hype prediction price

    
  USD 0.93  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
Intrinsic
Valuation
LowRealHigh
0.740.741.02
Details
Naive
Forecast
LowNextHigh
0.840.840.84
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.900.940.98
Details

Nemaura Medical After-Hype Price Prediction Density Analysis

As far as predicting the price of Nemaura Medical at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Nemaura Medical or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of Nemaura Medical, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Nemaura Medical Estimiated After-Hype Price Volatility

In the context of predicting Nemaura Medical's pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Nemaura Medical's historical news coverage. Nemaura Medical's after-hype downside and upside margins for the prediction period are 0.93 and 0.93, respectively. We have considered Nemaura Medical's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
0.93
0.93
After-hype Price
0.93
Upside
Nemaura Medical is very steady at this time. Analysis and calculation of next after-hype price of Nemaura Medical is based on 3 months time horizon.

Nemaura Medical Pink Sheet Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Nemaura Medical is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Nemaura Medical backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Nemaura Medical, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
 0.00  
0.00
 0.00  
 0.00  
0 Events / Month
11 Events / Month
Uncertain
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
0.93
0.93
0.00 
0.00  
Notes

Nemaura Medical Hype Timeline

Nemaura Medical is now traded for 0.93. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Nemaura is projected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is projected to be very small, whereas the daily expected return is now at 0.0%. %. The volatility of related hype on Nemaura Medical is about 0.0%, with the expected price after the next announcement by competition of 0.93. About 48.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 0.39. Nemaura Medical last dividend was issued on the 5th of December 2019. The entity had 1:10 split on the 5th of December 2019. Given the investment horizon of 90 days the next projected press release will be uncertain.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

Nemaura Medical Related Hype Analysis

Having access to credible news sources related to Nemaura Medical's direct competition is more important than ever and may enhance your ability to predict Nemaura Medical's future price movements. Getting to know how Nemaura Medical's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Nemaura Medical may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
NPCENeuropace 1.26 10 per month 3.04  0.14  9.73 (6.20) 35.79 
CVRXCVRx Inc 0.03 10 per month 3.77  0.09  9.25 (8.95) 41.08 
OFIXOrthofix Medical 0.44 9 per month 1.88  0.04  3.87 (3.15) 12.11 
AORTArtivion(1.02)7 per month 1.44  0.10  2.86 (2.42) 9.51 
HSKAHeska 0.15 8 per month 0.00  0.21  3.63 (0.71) 21.36 
BJDXBluejay Diagnostics(0.20)4 per month 11.28  0  14.89 (15.29) 120.57 
MOVEMovano Inc(0.30)9 per month 5.97  0.04  11.06 (9.04) 61.96 
INVOINVO Bioscience 0.57 3 per month 4.69  0.03  6.67 (6.85) 105.62 
NVNOenVVeno Medical Corp 0.21 5 per month 0.00 (0.21) 3.99 (6.65) 29.78 
MODDModular Medical(0.15)7 per month 0.00 (0.26) 2.79 (4.76) 17.34 
NXLNexalin Technology 0.04 8 per month 7.53  0.21  25.71 (14.05) 72.16 
SSKNSTRATA Skin Sciences 0.03 10 per month 3.36 (0) 5.28 (5.25) 16.58 
AIMDWAinos Inc 0.00 3 per month 19.99  0.09  76.79 (42.86) 187.07 
ELMDElectromed 1.21 9 per month 2.01  0.17  5.30 (3.90) 12.17 
ARMMArmm Inc 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
SRDXSurModics 0.06 8 per month 0.49 (0.03) 1.06 (0.93) 3.22 

Nemaura Medical Additional Predictive Modules

Most predictive techniques to examine Nemaura price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Nemaura using various technical indicators. When you analyze Nemaura charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Nemaura Medical Predictive Indicators

The successful prediction of Nemaura Medical stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Nemaura Medical, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Nemaura Medical based on analysis of Nemaura Medical hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Nemaura Medical's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Nemaura Medical's related companies.

Story Coverage note for Nemaura Medical

The number of cover stories for Nemaura Medical depends on current market conditions and Nemaura Medical's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Nemaura Medical is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Nemaura Medical's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Nemaura Medical Short Properties

Nemaura Medical's future price predictability will typically decrease when Nemaura Medical's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Nemaura Medical often depends not only on the future outlook of the potential Nemaura Medical's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Nemaura Medical's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding24.9 M
Cash And Short Term Investments10.1 M
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.

Other Consideration for investing in Nemaura Pink Sheet

If you are still planning to invest in Nemaura Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Nemaura Medical's history and understand the potential risks before investing.
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities